Products
  1. Home
  2. Products
  3. Inhibitors & Activators for IBD Research
Products
Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Sibofimloc

Cat. No.: IBDI-431403

Sibofimloc (Antibiotic-202) is a first-in-class, gut-restricted, orally active FimH adhesion inhibitor extracted from patent WO2014100158A1, Compound Example 202. Sibofimloc has anti-bacterial infective activity. Sibofimloc is developed for inflammatory bowel disease (IBD).

Size (Solution): 10 mM * 1 mL in DMSO

Size (Solid + Solvent): 10 mM * 1 mL ready for reconstitution

Size (Solid):

Product Details

Target Bacterial | Antibiotic
Molecular Weight 649.68
Appearance Solid
Synonyms Antibiotic-202
SMILES CC(N(CC1)CCC21C3=CC(C#C[[email protected]@H]4[[email protected]@H](O)[[email protected]@H](O)[[email protected]](O)[[email protected]@H](CO)O4)=CC=C3C5=CC=C(C#C[[email protected]]6O[[email protected]](CO)[[email protected]@H](O)[[email protected]](O)[[email protected]@H]6O)C=C52)=O
Purity 99.63%

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Powder: -20°C, 3 years; 4°C, 2 years
In solvent: -80°C, 6 months; -20°C, 1 month
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.
Copyright © Ace Therapeutics. All rights reserved.